DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Dent R, Im SA, Espie M. et al.
Overall survival update of the double-blind placebo-controlled randomised phase 2 LOTUS trial of first-line Ipataserib + paclitaxel for locally advanced/metastatic triple-negative breast cancer.
J Clin Oncol 2018;
36 (no.15_suppl): 1008
doi:10.1200/JCO.2018.36.15_suppl.1008
We do not assume any responsibility for the contents of the web pages of other providers.